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Plai cream (Zingiber cassumunar Roxb.) has been used as a remedy for release pain and inflammation of 
musculoskeletal problems. The enhancement of the anti-inflammatory effect of Plai cream by phonoporesis or ultrasound 
therapy is questionable. The aim of this study was to evaluate the effect of Plai cream combined with ultrasound in the 
treatment of delayed onset muscle soreness (DOMS). Seventy-five volunteers were randomly allocated into 3 groups; 14 % 
Plai cream (5 cm long strip), ultrasound treatment (1MHz, 1watt.cm-2) for 5 min, and combined 14 % Plai cream and 
ultrasound for 5 min. The participants performed eccentric exercise (4 sets of 25 repetitions at a speed of 60°.s-1) of 
dominant quadriceps using isokinetic dynamometry to induce DOMS. All participants received their allocated treatment 
once per day for the next 7 days. We found pain score, thigh circumference and serum creatine kinase were increased, while 
pressure pain threshold and muscle strength were decreased, but small changes of joint motion after intensive exercise  
(post-exercise day 1, 2, 3 & 7). However, there was no significant difference changes of all outcomes among three groups. 
In conclusion, combined 14 % Plai cream with ultrasound had no additional benefit at reducing DOMS compared to 
either14 % Plai cream alone or ultrasound alone.  
Keywords: Plai cream, Phonophoresis, Muscle soreness, Muscle strength, Creatine kinase 
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Delayed onset muscle soreness (DOMS) illustrated as 
muscle pain and tenderness typically occurs after 
strenuous eccentric exercise, especially unfamiliar 
exercise1. The symptoms associated with DOMS that 
normally occur 24-48 hrs after exercise2 derive from 
exercise induced sarcomere disruption and the 
secondary inflammatory response3-4. Non-steroidal anti-
inflammatory drugs (NSAIDs) are one of numerous 
methods prescribed for DOMS management that may 
improve the muscle pain, stiffness, swelling and 
function loss accompanying DOMS. The NSAIDs 
inhibit cyclooxygenase activity, subsequently reducing 
prostaglandins and inflammatory processes5-6. 
Plai or Zingiber cassumunar Roxb. is widely used 
in Thailand as traditional medicine for anti-
inflammation and pain reduction. Plai cream is 
thought to inhibit cyclooxgenase, cyclooxygenase-2 
and lipoxygenase pathways7-8, similar to the anti-
inflammatory effects of NSAID’s. Previous clinical 
trials revealed application of Plai cream has beneficial 
effects in decreasing symptoms of ankle sprain9, knee 
osteoarthritis10 and muscle strain11. In a recent study, 
Plai cream at a concentration of 14 % reduced DOMS 
pain significantly12. 
Ultrasound is commonly used in physiotherapy to 
relieve pain and inflammation. Ultrasound as 
phonophoresis has also been used to enhance 
transdermal penetration of pharmacological 
substances13. Ultrasound in combination with 
diclofenac gel for management to osteoarthritis 
patients was found to improve pain at rest and 
activity, the Western Ontario and McMaster 
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Universities Arthritis Index (WOMAC) pain score 
and physical function after treatment compared to 
either diclogenac gel alone or ultrasound therapy 
alone14. Ultrasound and phonophoresis has also been 
showed with beneficial effects on other 
musculoskeletal disorders such as painful shoulder 
syndrome and lateral epicondylitis15-16. The evidence 
for the use of phonophoresis for the management of 
DOMS has some merit with a study showing that 
using ultrasound combined with trolamine salicylate 
cream on 3 consecutive days after eccentric exercise 
reduced muscle soreness by 24.4 % compared to 
trolamine salicylate cream alone and reduced muscle 
soreness by 51.7 % compared to ultrasound alone17. 
However, while phonophoresis has been successfully 
used with other products to reduce DOMS symptoms, 
the combination of ultrasound with Plai oil for the 
reduction of DOMS symptoms has not been 
investigated. 
This study aims to evaluate the therapeutic effect of 
Plai cream combined with ultrasound on subsequent 
DOMS symptoms compared to only Plai cream or 
ultrasound alone. If the anti-inflammatory effect of 
Plai cream can be enhanced by phonoporesis, it could 
be an alternative management for individuals with 
DOMS. 
 
Methods 
This clinical trial was conducted at the exercise 
laboratory, Rehabilitation Department, KhonKaen 
University, Thailand. Seventy-five healthy volunteers 
aged 18–60 yrs were included in this study. 
Participants who suffered serious medical diseases 
such as diabetes, hypertension and heart disease were 
excluded. The included participants were asked to sign 
consent forms before commencing the experiment. The 
study was approved by the KhonKaen University 
Ethics Committee for Human Research (Ref. No. HE 
561436), and was registered at Thai Clinical Trial 
Registry (ID. No. TCTR20150628001).  
 
Exercise induced DOMS 
Strenuous eccentric exercise of the quadriceps 
muscle was performed to generate DOMS using an 
isokinetic dynamometer (Primus RS, BTE 
technologies, Hanover, MD, USA). Fifteen minutes of 
low intensity and active stretching exercises were 
used to warm-up the lower limbs prior to start the 
eccentric exercise. Four sets of 25 maximum eccentric 
contractions of the dominant knee was performed at a 
speed of 60°.s-1 with 10 s rest between repetitions and 
3 min rest between each set. The knee movement 
started from flexion (90°) to full extension (0°) with the 
rotational axis of knee movement of the dynamometer 
positioned at the lateral femoral epicondyle. The 
participants were verbally encouraged to give maximal 
efforts during the exercise. The exercise protocol has 
been used previously to successfully induce 
DOMS12.The participants were allocated by block 
randomization into 3 groups; group 1, (Plai cream), 
group 2 (ultrasound), and group 3 (combined Plai 
cream and ultrasound). For group1, a dose of 2 gm or 
approximately a 2.5 cm long strip of 14 % Plai cream 
was gently massaged with hand on to the quadriceps 
muscles around 5 min or until the cream was not 
visible, immediately following the eccentric exercise. 
The participants were then instructed to apply a 
similar amount of Plai cream every 8 hrs after 
exercise. The Plai cream was manufactured by 
Bangkok Lab & Cosmetic Co., Bangkok, Thailand 
that has a GMP (Good Manufacturing Practice) and 
PIC/S GMP standard. For group 2, a certified 
physiotherapist applied continuous ultrasound wave 
therapy17 with 1 MHz frequency and 1.5 watt.cm-2 on 
to the quadriceps muscle area of participants for 5 min 
immediately following the eccentric exercise and then 
every day. The transducer head was applied at a right 
angle to ensure maximum energy absorption. The skin 
was coated with acoustic gel which did not contain 
any pharmacological substances. Finally for group 3, 
the participants received the same ultrasound therapy 
as group 2 and used a 2.5 cm long strip of Plai cream 
(14 % Plai cream) as a replacement for acoustic gel. 
The compliance of participants using the treatments 
was observed on daily basis along with any other 
treatments they required (including analgesic relief, 
NSAID, physiotherapy or massage). 
 
Measurement 
The muscle strength, perceived muscle soreness, 
pressure pain threshold, rate of perceived exertion, range 
of motion and thigh circumference were measured at 
baseline, day 1, day 2, day 3, and day 7 post-exercise. 
Plasma creatine kinase activity was measured at 
baseline, day 1, day 2 and day 3 post-exercise. 
 
Pain score 
The perceived muscle soreness was evaluated by a 
visual analogue scale ranged from 0 for no pain, to 10 
for the worst pain. The visual analog scale has been 
widely accepted as a reliable method to assess the 
level of pain intensity18  
INDIAN J TRADIT KNOWLE, VOL. 16, No. 3, JULY 2017 
 
 
444 
Muscle strength 
Participant’s muscle strength was evaluated during 
a 3-second maximal isometric voluntary concentric 
(MVC) of their dominant quadriceps by using 
dynamometry. All participants were seated while their 
dominant leg was secured to the isokinetic 
attachment. Each participant performed three MVCs 
(2min rest between each) with the knee flexed at 90o 
with verbal encouragement. The average of two 
closest trials was recorded. Muscle strength and 
muscle soreness were measured immediately prior to 
eccentric exercise, and then again at the same time of 
day on days 1, 2, 3, 4 and 7 post-exercise. 
 
Plasma creatine kinase (CK) 
The level of plasma CK was analyzed from a 5-ml 
blood sample which was taken from the median 
cubital vein after 5 min seated rest. The plasma CK 
was collected at the same time in the morning. The 
analysis of plasma CK was performed by using an 
automated analyzer (Cobas® 6000 analyzer; Roche 
Diagnostics Corp., Indianapolis, IN, USA) at 
Srinagarind Hospital Laboratory at baseline, day 1, 
day 2 and day 3 post-exercise.  
 
Pressure pain threshold 
Pressure pain threshold of the dominant quadriceps 
was measured by a manual algometer (Baseline® 
algometer, Fabrication Enterprises Inc., White Plains, 
NY, USA). An allocation-blinded research assistance 
pressed the algometer perpendicularly to quadriceps 
muscle and recorded the minimal pressure which 
produced a painful sensation. The pressure test was 
conducted while participants were on an examination 
bench with their knee joint extended. The average of 
three points measured on the quadriceps (5, 10, and 
15 cm above the apex of patella) was recorded. 
 
Rate of perceived exertion (RPE) 
The participant rated perceived exertion by using 
the Borg scale (ranged from 6 to 20)15 recorded at the 
laboratory after 5 min rest each testing day. 
 
Range of motion (ROM) 
The range of motion of the tested knee joint was 
measured to evaluate the degree of joint stiffness from 
muscle soreness. The research assistance used a 
goniometer (Baseline® goniometer, Fabrication 
Enterprises Inc., White Plains, NY, USA) to measure 
the degree of knee motion in a prone position from 
full extension to full knee flexion. 
Thigh circumference 
Thigh circumference of participants was evaluated 
to indicate muscle swelling in supine position by a 
blinded research assistant. The measurement was 
performed at the midpoint between inguinal fold and 
anterior aspect of the patella by using a standard tape 
(Rollfix, Hoechst. Mass, Germany). The circumferences 
were measured to the nearest 0.1 cm and the mean of the 
two closest measurements (of a total of 3 measures) was 
recorded.  
 
Statistical analysis 
The study results are presented by descriptive 
statistics including the mean and standard deviation. 
Overall effects and differences in pain score, pressure 
pain threshold, rate of perceived exertion, creatine 
kinase, muscle strength, range of motion and thigh 
circumference among three groups during the baseline 
and recovery time periods were analyzed using a 
repeated measures analysis of variance (ANOVA) and 
post hoc analysis. The statistical analysis of statistic was 
conducted using STATA (version 13.0) with a p < 0.05. 
 
Results 
The characteristics of the participant groups are 
presented in the Table 1 (n = 75, age 41.5 ± 9.3 yrs, 
BMI 24.2 ± 3.9 kg.m-2, mean ± SD, 6 male and  
44 female). There was no drop out and additional 
treatments such as analgesic, NSAID or massage were 
not observed. The visual analog pain score 
significantly increased post-exercise day 1 (p < 0.01) 
in all 3 groups and slowly decreased until  
post-exercise day 7. The pain score of the combined 
Plai cream with ultrasound group was lower than 
Plai cream group alone (mean difference = -2.0,  
95 % CI - 8.8 to 4.8, p = 0.6) or ultrasound group 
alone (-2.1, -8.9 to 4.6, p = 0.5), but this difference 
did not reach statistical significance (Table 2). The 
muscle strength (MVC) decreased within the first  
2 days’ post-exercise (p < 0.01) similar to pressure 
pain sensation (p < 0.01) and gradually improved 
over the week. The serum CK and thigh 
circumference was significantly increased at  
post-exercise day1 (p < 0.01) and slowly returned 
to baseline. Little changes of range of motion and 
rate of perceived exertion were observed 
throughout the experiment. Statistical testing 
showed there was no significant difference of 
MVC, pressure pain threshold, serum CK, range of 
motion, rate of perceived exertion and thigh 
circumference among the three groups (Tables 2&3). 
MANIMMANAKORN et al.: EFFECT OF PLAI CREAM COMBINED WITH ULTRASOUND ON MUSCLE SORENESS 
 
 
445 
Discussion 
This study showed the eccentric exercise program 
is effective at inducing DOMS by significantly 
increasing the pain score, thigh circumference and 
creatine kinase release, and decreasing pressure pain 
threshold and muscle strength compared to baseline in 
each group; 14 % Plai cream, ultrasound and 14 % 
Plai cream combined with ultrasound. However, this 
study found no substantial difference in pain score, 
pain pressure threshold, rate of perceived exertion, 
creatine kinase, muscle strength, range of motion and 
thigh circumference during a recovery from eccentric 
exercise among the 3 intervention groups. The 
combination of 14 % Plai cream and ultrasound did 
not show any greater effect than 14 % Plai cream or 
ultrasound alone. Application of 14 % Plai cream may 
have similar effect on DOMS to ultrasound therapy. 
The mechanisms that were thought to be responsible 
for DOMS include sarcomere disruption and secondary 
inflammation from muscle damage3-4. The inflammation 
process stimulates Prostaglandin E2 to sensitize type III 
and IV pain afferents, and leukotrienes to attract 
neutrophils for producing free radicals that exacerbate 
muscle cell damage2. Previous studies revealed various 
phytochemical extracts from Plai can reduce pain and 
inflammation19-21. Extracts from Plai such as curcumin 
(diferuloylmethan), casumunar, (E)-1-(3,4-
dimethoxyphenyl) but-3-en-2-ol and (E)-1-(3,4-
dimethoxyphenyl) butadiene (DMPBD) are thought to 
reduce edema and inflammation through inhibition of 
cyclooxygenase, lipoxygenase pathways8, resulting in 
less exudate formation and leukocyte accumulation20.  
Previous clinical trials found Plai cream 
significantly reduced pain from ankle sprain9, 
osteoarthritis10 and muscle strain11. A recent clinical 
trial found a dose-response effect of Plai cream and 
suggested a concentration of 14 % Plai cream is 
required to reduce pain associated with DOMS12. This 
study using the same treatment protocol and the same 
concentration of Plai cream (14 %) corroborated this 
earlier study by showing a reduction in pain 
associated with DOMS. 
It has been suggested ultrasound therapy generates 
oscillatory movement in the tissue which may cause 
decreased pain and inflammation22. Hasson et al. 
(1990) suggested pulsed ultrasound therapy could 
Table 1 — Demographic data of participants 
 
 
Plai cream 
n= 25 
Ultrasound 
n = 25 
Combined 
n = 25 
    
Male/Female 3/22 3/22 3/22 
Age (yrs) 41.7 ± 9.9 41.3 ± 9.0 41.6 ± 9.4 
Body weight (kg) 60.4 ± 13.3 58.9 ± 8.8 59.9 ± 6.7 
BMI (kg.m-2) 24.6 ± 4.9 24.1 ± 3.5 23.5 ± 3.2 
Data are means ± SD    
 
Table 2 — Pain score, muscle strength and creatine kinase 
concentration of the three groups (mean ± SD) at baseline, and post-
exercise days. 
    
 Plai cream Ultrasound Combined 
Pain score    
Baseline 0.5 ± 0.6  0.5 ± 0.5 0.4 ± 0.4 
Post-exercise day 1 3.0 ± 2.2* 3.1 ± 2.1* 2.7 ± 1.9* 
Post-exercise day 2 2.1 ± 1.7* 2.3 ± 2.1* 1.9 ± 1.7* 
Post-exercise day 3 1.4 ± 1.2* 1.5 ± 1.5* 1.2 ± 1.5* 
Post-exercise day 7 0.6 ± 1.0 0.5 ± 0.7 0.4 ± 0.4 
Muscle strength (kg) 
Baseline 35.6 ± 7.6 34.8 ± 7.9 36.7 ± 7.0 
Post-exercise day 1 34.4 ± 7.8* 32.2 ± 6.7* 34.9 ± 5.5* 
Post-exercise day 2 32.8 ± 7.4* 32.8 ± 6.0* 34.0 ± 7.2* 
Post-exercise day 3 34.3 ± 8.4 34.0 ± 6.9 35.5 ± 6.2 
Post-exercise day 7 33.3 ± 8.7 34.7 ± 7.9 35.7 ± 7.0 
Creatine kinase (mmol.L-1) 
Baseline 116.1 ± 41.6 128.9 ± 44.9 127.8 ± 43.3 
Post-exercise day 1 168.6 ± 101.9* 167.3 ± 83.6* 170.7 ± 116.9* 
Post-exercise day 2 148.9 ± 90.0 148.6 ± 67.0 153.4 ± 91.2 
Post-exercise day 7 131.1 ± 56.2 140.8 ± 78.0 134.1 ± 49.4 
    
*Significant difference compared to baseline (p < 0.05) 
Table 3 — Pressure pain threshold, rate of perceived exertion 
(RPE), range of motion, thigh circumference of the three groups 
(mean ± SD) at baseline, and post-exercise days. 
 
 Plai cream Ultrasound Combined 
Pressure pain threshold (kg.cm-2) 
Baseline 2.9 ± 1.1 3.0 ± 1.0 3.5 ± 1.8 
Post-exercise day 1 2.3 ± 1.4* 2.5 ± 1.3* 2.6 ± 1.4* 
Post-exercise day 2 2.4 ± 1.4* 2.7 ± 1.3 2.8 ± 1.4* 
Post-exercise day 3 2.4 ± 1.4* 2.7 ± 1.4 2.8 ± 1.4* 
Post-exercise day 7 2.5 ± 1.3 3.0 ± 1.3 3.1 ± 1.4 
RPE 
Baseline 8.1 ± 1.6 8.2 ± 2.0 8.4 ± 1.9 
Post-exercise day 1 8.8 ± 1.9 8.4 ± 1.6 9.3 ± 2.4 
Post-exercise day 2 7.9 ± 1.2 8.2 ± 1.6 8.5 ± 1.9 
Post-exercise day 3 7.9 ± 2.3 7.9 ± 1.9 8.3 ± 1.8 
Post-exercise day 7 7.9 ± 1.7 7.4 ± 1.2 7.2 ± 0.9 
Range of motion (degree) 
Baseline 128.2 ± 9.9 125.8 ± 8.5 128.2 ± 7.8 
Post-exercise day 1 125.8 ± 8.4 126.6 ± 7.0 127.0 ± 6.3 
Post-exercise day 2 125.8 ± 8.0 126.6 ± 6.7 126.0 ± 6.1 
Post-exercise day 3 126.2 ± 8.1 127.0 ± 6.6 126.2 ± 6.2 
Post-exercise day 7 126.8 ± 8.4 126.6 ± 6.3 127.2 ± 6.8 
Thigh circumference (cm) 
Baseline  47.5 ± 6.0 47.3 ± 3.1 47.1 ± 4.1 
Post-exercise day 1 48.0 ± 5.5* 47.8 ± 3.4* 47.9 ± 4.2* 
Post-exercise day 2 48.0 ± 5.7* 47.8 ± 3.4* 47.8 ± 4.3* 
Post-exercise day 3 48.1 ± 5.7* 47.7 ± 3.2* 47.9 ± 4.3* 
Post-exercise day 7 47.9 ± 5.8* 47.7 ± 3.3* 47.9 ± 4.4* 
    
*Significant difference compared to baseline (p < 0.05) 
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reduce pain associated with DOMS23. Craig et al. 
(1999) found no substantial effect of ultrasound on 
DOMS22. However, the participants in the group 
who received high pulsed ultrasound had the lowest 
level of muscle soreness. Parker et al. (2014) 
suggested placebo effect to relieve pain of 
ultrasound therapy for DOMS since they did not find 
different effect between ultrasound and sham24. 
Accordingly, our study found the effect of 
ultrasound was not different to 14 % Plai cream. 
Phonophoresis in this study was unsuccessful for 
enhancing any beneficial effects of the Plai cream. 
While phonophoresis with other phytochemicals 
(e.g. Aloe vera, Arnica montana) has shown mixed 
results25-26, evidence exists for a beneficial effect of 
phonophoresis using continuous ultrasound  
(1MHz, 1.5 Watt.cm-2, 5 min) and trolamine 
salicylate for DOMS management17. This study, we 
used the ultrasound with the same parameters as 
Ciccone’s study; however, our study found 
ultrasound combined with Plai cream did not have 
any substantially greater effect than Plai cream or 
ultrasound treatments alone. We hypothesize that the 
phonophoresis with Plai cream in this study which 
used compound phytochemical substances (e.g. 
curcumin or casumunar) may act differently under 
ultrasound than tropical trolamine salicylate. 
The limitation of this study is there was no placebo 
cream group to reveal the profound beneficial effect 
of 14 % Plai cream and ultrasound. In addition, the 
higher than expected variation in the measures taken 
resulted in the study being inadequately powered. We 
would recommend any future research in this area to 
incorporate larger sample sizes. 
 
Conclusion 
Combining 14 % Plai cream with ultrasound had 
no additional benefit on symptoms associated with 
DOMS compared to 14 % Plai cream or ultrasound 
intervention alone. Ultrasound may not be useful at 
enhancing Plai extract skin penetration by 
phonophorosis. 
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